Discover how genetic profiles and ancestry may influence the underlying neuropathology and diagnostic accuracy of ...
"Alzheimer's disease impacts too many people, more than breast cancer and prostate cancer combined." ...
The findings, published in Cureus, come from a study led by Bindu N from the Department of General Surgery, Sri Devaraj Urs ...
Objective: To investigate the effects of the flipped classroom health education model based on the WeChat platform on disease ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an ...
Disorders of Consciousness (DOC) result from focal to global brain injuries. They present a crucial challenge to neurologists and neurorehabilitation ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...
Morning Overview on MSN
A finger-prick test taken at home may reveal your dementia risk
Researchers have shown that a simple finger prick performed at home, without medical supervision, can detect a protein linked to Alzheimer’s disease severity. The dried blood samples, collected on ...
Tech Times on MSN
Tau therapy slows Alzheimer's decline in first human trial as AAIC 2026 wraps in London
Alzheimer's treatment 2026 reached an inflection point at AAIC 2026 in London: diranersen showed the first tau-targeting ...
For researchers on the hunt for the genetic roots of disease, the cost of deep whole-genome sequencing makes it challenging ...
When it comes to statistics, we usually expect to be informed about what happens "on average." But sometimes the key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results